about
Mammalian target of rapamycin (mTor) mediates tau protein dyshomeostasis: implication for Alzheimer diseaseIncreased tau phosphorylation and impaired presynaptic function in hypertriglyceridemic ApoB-100 transgenic miceCB(2) cannabinoid receptor antagonist SR144528 decreases mu-opioid receptor expression and activation in mouse brainstem: role of CB(2) receptor in pain.Dysregulated mTOR-dependent signaling in neurodegeneration or carcinogenesis: implication for Alzheimer's disease and brain tumors.Altered gene expression and functional activity of opioid receptors in the cerebellum of CB1 cannabinoid receptor knockout mice after acute treatments with cannabinoids.Noladin ether, a putative endocannabinoid, inhibits mu-opioid receptor activation via CB2 cannabinoid receptors.Comparison of Various Types of Ligand Decorated Nanoliposomes for their Ability to Inhibit Amyloid Aggregation and to Reverse Amyloid Cytotoxicity.mTor is a signaling hub in cell survival: a mass-spectrometry-based proteomics investigation.Cholesterol and cholesterol plus DHA diet-induced gene expression and fatty acid changes in mouse eye and brain.Capillary injury in the ischemic brain of hyperlipidemic, apolipoprotein B-100 transgenic mice.Bruch's membrane changes in transgenic mice overexpressing the human biglycan and apolipoprotein b-100 genes.Overexpression of human apolipoprotein B-100 induces severe neurodegeneration in transgenic mice.Synaptic proteins predict cognitive decline in Alzheimer's disease and Lewy body dementia.APP mRNA splicing is upregulated in the brain of biglycan transgenic mice.Repeated intraperitoneal injections of liposomes containing phosphatidic acid and cardiolipin reduce amyloid-β levels in APP/PS1 transgenic mice.Human apoB overexpression and a high-cholesterol diet differently modify the brain APP metabolism in the transgenic mouse model of atherosclerosis.mTOR-mediated hyperphosphorylation of tau in the hippocampus is involved in cognitive deficits in streptozotocin-induced diabetic mice.Unfolded protein response is activated in Lewy body dementias.Overexpression of biglycan in the heart of transgenic mice: an antibody microarray study.Biglycan protects cardiomyocytes against hypoxia/reoxygenation injury: Role of nitric oxideHypercholesterolemia increases myocardial oxidative and nitrosative stress thereby leading to cardiac dysfunction in apoB-100 transgenic mice
P50
Q30412891-B353F71F-E492-472D-8DC2-A9AE89C69A27Q34430592-65856D6D-802B-4D81-AEB7-9EB9FDCDABA2Q34832014-D098A2A7-AE93-4AA4-A53F-E25DBE12B0D0Q38129230-A32BF5CB-5225-4725-BC3C-33E8378B4BBBQ38293258-86F768D1-DD9B-4E5E-83D6-4FF2519118AAQ38299191-22080968-9577-4889-9B4A-ECBF483915FAQ38867540-70317607-3595-4743-8C54-AE44B32DB9B9Q39008937-F43A00F4-6FAB-4AEB-B920-B9C429B1B8FFQ42642291-BFB3D341-55AB-4A8D-9EB8-443B86057AB9Q46028216-4BCBE625-7289-47FF-AF25-357C6C4D3721Q46073259-0BEA095D-BD6E-4304-B321-D5186F9108E5Q46600323-F8402EDD-C294-4D8B-AF6F-6FFF488E05D1Q48016761-945B4F87-F843-4EC1-9E74-08E91A3FFE37Q48424704-4226A38F-4B25-407A-8DF4-C79BF5193649Q48429491-F2D5227A-5EF8-42B9-9C9C-5CAC248AD0F2Q48613197-969A7255-53F2-4539-839C-A9056005A692Q50674022-648D30F7-EB27-4156-8858-65DE5FE10286Q53478472-B9F618D3-5A97-4006-BB30-0E0EDD356DC2Q54558788-907CE76A-E15B-48A0-845C-FA7B2A0560C5Q57723334-62B28FD1-0BA0-4308-BF64-39057D1E41EBQ57723354-1AE6831F-632D-4DC2-B27C-41456324EAF0
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Erika Bereczki
@ast
Erika Bereczki
@en
Erika Bereczki
@es
Erika Bereczki
@nl
Erika Bereczki
@sl
type
label
Erika Bereczki
@ast
Erika Bereczki
@en
Erika Bereczki
@es
Erika Bereczki
@nl
Erika Bereczki
@sl
prefLabel
Erika Bereczki
@ast
Erika Bereczki
@en
Erika Bereczki
@es
Erika Bereczki
@nl
Erika Bereczki
@sl
P106
P21
P31
P496
0000-0002-0373-7417